Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|October 28, 2003
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Potent twice-weekly rifapentine-containing regimens in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
Mycobacterial Diseases : Tuberculosis & Leprosy|December 20, 2014
Revisiting Anti-tuberculosis Activity of Pyrazinamide in MiceDeepak V Almeida, Sandeep Tyagi, Si-Yang Li, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2005
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosisSandeep Tyagi, Nicole C Ammerman, Si-Yang Li, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2010
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pigZahoor Ahmad, Eric L Nuermberger, Rokeya Tasneen, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2009
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosisKathy N Williams, Steven J Brickner, Charles K Stover, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans diseasePaul J Converse, Yalan Xing, Ki Hyun Kim, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosisIan M Rosenthal, Rokeya Tasneen, Charles A Peloquin, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2013
Assessment of clofazimine activity in a second-line regimen for tuberculosis in miceJacques H Grosset, Sandeep Tyagi, Deepak V Almeida, et al.
Pageof 6